跳至主要内容
临床试验/NCT05066360
NCT05066360已完成不适用

Investigation of Serum Antimullerian Hormone Levels in Adolescent Epilepsy Patients

Near East University, Turkey2 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2021年7月2日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
60
试验地点
2
主要终点
serum anti-mullerian hormone levels

研究概览

简要总结

The production of AMH starts in granulosa cells before birth and the levels within the serum decreases towards the menapouse. The levels of AMH do not change throughout the menstruation cycle hovewer, it can be affected in cases related to body mass index (BMI), polycyctic ovarian syndrome (PCOS). The lower levels of AMH had been documented after ovarian surgery, radiotheraphy and chemotheraphy. AMH is a member of Transforming Growth Faktor β (TGF- β ) and it has receptors in brain structures including hyppocammpus. It is highly active neurophysiologically and it has a protective effect against N-methyl-D -aspartate related neuronal injury that is demonstrated both in vivo and in vitro studies. As a result, being a neuroactive hormone; AMH may have an effect on seizures within epileptic patients or serum AMH levels may be effected in epileptic patients when compared with healthy ones.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Parallel
主要目的
Diagnostic
盲法
None

入排标准

年龄范围
12 Years 至 18 Years(Child, Adult)
性别
Female
接受健康志愿者

入选标准

  • Healthy and epileptic volunteer females
  • Ages between 12-18
  • After menarche

排除标准

  • ovarian surgery,
  • history of radiotherapy
  • history of chemotherapy,
  • before menarche

结局指标

主要结局

serum anti-mullerian hormone levels

时间窗: baseline, at the time of examination

The comparison of serum levels of anti-mullerian hormone between epileptic and healthy groups

次要结局

未报告次要终点

研究者

发起方
Near East University, Turkey
申办方类型
Other
责任方
Principal Investigator
主要研究者

Ali Cenk

Medical Doctor, Associate Professor

Near East University, Turkey

研究点 (2)

Loading locations...

相似试验